Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 71M | 59M | 49M |
| Cost of revenue | 64M | 52M | 42M |
| Gross profit | 7M | 7M | 7M |
| Research and development | 240,052 | 229,934 | 254,246 |
| Selling, general and administrative | 2M | 2M | 1M |
| Operating expenses | 3M | 2M | 1M |
| Operating income | 5M | 5M | 6M |
| Pre-tax income | 5M | 5M | 6M |
| Income tax | 677,421 | 537,771 | 1M |
| Net income | 4M | 5M | 5M |
| Earnings per share | 0.18 | 0.21 | 0.22 |
| Earnings per share, diluted | 0.18 | 0.21 | 0.22 |
| Weighted average shares | 22M | 22M | 22M |
| Weighted average shares, diluted | 22M | 22M | 22M |
| Metric | 18 Aug 2026 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|---|
| Cash and equivalents | — | 7M | 4M | 3M | 4M |
| Short-term investments | — | — | 2M | 1M | — |
| Current assets | — | 41M | 28M | — | — |
| Property, plant and equipment | — | 194,878 | 54,486 | — | — |
| Total assets | — | 41M | 28M | — | — |
| Current liabilities | — | 12M | 7M | — | — |
| Total liabilities | — | 13M | 9M | — | — |
| Equity | — | 28M | 19M | 15M | 10M |
| Shares outstanding | — | 23M | 22M | 22M | — |
| Shares issued | — | 23M | 22M | 22M | — |
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Operating cash flow | −6M | −693,959 | 1M |
| Depreciation and amortisation | 26,497 | 27,314 | 26,641 |
| Capital expenditure | 167,932 | 1,380 | — |
| Investing cash flow | 2M | −228,183 | −2M |
| Financing cash flow | 7M | 2M | 482,468 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator